Rocketing to a price of $53.23 during today's morning trading session, shares of Globus Medical are still -16.73% below their average target price of $63.92. Could there be more upside potential for the stock? Analysts are giving GMED an average rating of hold and target prices ranging from $53.0 to $86.0 dollars per share.
It seems the market sentiment regarding Globus Medical is mostly optimistic, since it has a short interest of only 2.8%. This is the percentage of the share float that is being shorted by investors who are hoping the stock's price will decrease in the future.
Short selling involves borrowing shares and then selling them at current market prices. In the successful version of the strategy, the shares are purchased at a lower price at some time in the future. The investor then returns the shares to the lender, and keeps the profit made on the sell/buy transaction.
One way to get an idea of the market sentiment on a stock is to check its rate of institutional ownership. In the case of Globus Medical, institutional investors own 96.4% of the shares. This would indicate a positive sentiment towards the stock among institutions. What does this really tell us?
Institutional investors such as hedge funds, investment firms, and wealth managers devote significant resources to identifying good investments. If they have decided to invest in GMED, it probably means they believe it is a solid investment choice. But it could also mean they are buying up shares in an effort to acquire the company or get seats on the board of directors. Also bear in mind that institutions are fallible (just maybe not quite as fallible as the average retail investor), so they may simply be wrong when they think they've found a good stock.
In conclusion, we see mixed market sentiment regarding Globus Medical because of an analyst consensus of some upside potential, a hold rating, an average amount of shares sold short, and a significant number of institutional investors. At Market Inference, we believe that any investment decision should be preceded by an in-depth analysis of the company's fundamental values and a comparison with similar stocks.
Here's a snapshot of some important facts to keep in mind about GMED:
-
The stock has trailing 12 month earnings per share (EPS) of $1.47
-
Globus Medical has a trailing 12 month Price to Earnings (P/E) ratio of 36.2 compared to the S&P 500 average of 15.97
-
The company has a Price to Book (P/B) ratio of 1.79 in contrast to the S&P 500's average ratio of 2.95
-
Globus Medical is a Health Care company, and the sector average P/E and P/B ratios are 30.21 and 4.08 respectively
